Dynamic Multi-Analyte Technology (DMAT®) offers simultaneous end-point and real-time measurement of multiple biomarkers with minimum assay variability. It supports a variety of assay formats, such as sandwich assays for measuring biomarkers and (in)direct assays for quantifying specific antibodies in samples.
Evalution® is an integrated system based on three elements: the instrument, the disposable: cartridge with micro-particles inside and the software containing advanced analysis algorithms. No additional equipment is required.
Cartridge with encoded microparticles
Software and data analysis algorithms
Evalution® Platform Configurations
MyCartis’ proprietary platform Evalution® is powered by DMAT®. It brings all the DMAT® benefits and features, such as ultra-fast real-time assays and minimal assay variability. Evalution® comes in 3 different configurations, each designed to provide a unique solution to life science R&D, clinical research and routine clinical diagnostics respectively.